Pulmatrix Competitors and Similar CompaniesClear all
Pulmatrix's competitors and similar companies include Ipsen and Vertex Pharmaceuticals.
 Pulmatrix Pulmatrix develops inhaled therapies for the treatment, prevention, and transmission of infectious and progressive respiratory diseases. |  Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines. | ||
Founding Date | Founding Date 2003 | Founding Date 1929 | Founding Date 1989 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Lexington, US HQ | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | |
Employees | Employees 228% decrease | Employees 5,358 | Employees 5,40013% increase |
Valuation ($) | Valuation ($) 8 m | Valuation ($) 10.2 b | Valuation ($) 121.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $12b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €659.1m (FY, 2025) | Cost of goods $1.7b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit $10.4b (FY, 2025) |
Net income | Net income ($5.2m) (FY, 2025) | Net income €445.1m (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 47.7m | Total funding raised N/A | Total funding raised $ 2.4m |
For sources of this data, please see the company profile
View Company Profiles
Vertex Pharmaceuticals
HQ
Boston, US
Employees
5,400↑ 13% increase
Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.
View company